Press releases in 2019

Cancer development is associated with the gradual accumulation of DNA defects over time. Thus, cancer is considered an age-related disease. But why do children develop cancer? An international team of researchers, led by Charité – Universitätsmedizin Berlin and the Memorial Sloan Kettering Cancer…

On December 16, the network “sheHealth – Women in Digital Health” is holding a conference on the topic of women and artificial intelligence in medicine. With regard to both the data with which AI algorithms are “fed” and to the AI developers themselves, women are underrepresented in the field of…

The Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin are the first institutions in Germany to receive funding to create a translational partnership with the UK-based Wellcome Trust. Via its translational partnerships, the Wellcome Trust supports institutions in finding new…

The European initiative RESTORE invites you to join its 1st Advanced Therapies Science Meeting (ATSM) in Berlin on November 25 and 26. The meeting will focus on advanced therapy medicinal products, often known as “advanced therapies” or “living drugs,” which aim to cure diseases rather than to…

Nerve cells communicate with one another via signaling molecules. The rule is: the more of these molecules, the stronger the signal. Drugs and diseases influence these processes and can weaken or strengthen the signal. Together with colleagues of Einstein BIH Visiting Fellow Thomas Südhof from…

There can be no new therapies without research, and there can be no medicine of the future without new ideas: But how do we make the leap from lab to patient care? What steps are necessary to turn a successful experiment into a product that benefits patients? The answer is called “translational…

On 27.10.2019 the World Health Summit will begin in Berlin, one of the most important international conferences for global health issues with more than 2,500 participants from 100 nations. Science, politics, the private sector and civil society come together here to discuss the challenges of global…

During Berlin Science Week and to mark the occasion of the Future Medicine Science Match 2019, the Berlin Institute of Health is holding a BIH Diversithon on November 6. The Diversithon is a Wikipedia edit-a-thon that aims to increase the visibility of women scientists and other underrepresented…

Translation is the key focus at the Berlin Institute of Health (BIH). The aim is to transfer promising results from the laboratory to clinical practice, and to use observations from daily clinical routine as inspiration for new research ideas. For this to happen, certain conditions must be in place.…

“Breaking the Wall of…” is the challenge that the Falling Walls Lab has posed to young scientists and entrepreneurs in about 100 cities around the world. The aim is to promote exceptional ideas and to connect promising scientists and entrepreneurs from all fields on a global level. Participants get…

Press release in German.

Antoinette Maassen van den Brink from Erasmus University Medical Center in Rotterdam is the recipient of this year’s BIH Excellence Award for Sex and Gender Aspects in Health Research of the Berlin Institute of Health (BIH). Together with her project partner at Charité – Universitätsmedizin Berlin,…

Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) intend to work closely with the Israel Innovation Authority to improve patient care through innovative healthcare ideas. The Israel Innovation Authority will provide extensive funding to selected projects in order to…

On September 1, Fabian Prasser from the Technical University of Munich (TUM) assumed the W3-Professorship for Medical Informatics at the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin. Together with his team at the BIH, the medical IT specialist will be primarily tasked…

The Berlin University Alliance, a consortium of three major Berlin universities and Charité – Universitätsmedizin Berlin, is dedicated to producing research of the highest quality. The research findings made within the Alliance aim to provide maximum benefit and thus increase public trust in…

On Wednesday, July 10, 2019, German Research Minister Anja Karliczek and Governing Mayor of Berlin Michael Müller signed an administrative agreement between the federal government and the state of Berlin that lays out the details for the integration of the Berlin Institute of Health (BIH) into…

Press release in German.

The unrestricted availability of original data – so-called open data – on scientific publications is an important prerequisite for ensuring research results are verifiable and able to be used in the best possible way. Moreover, the reproducibility of results is crucial for the transfer of research…

Around half a million people are diagnosed with cancer every year, and the trend is rising. In addition to surgery and radiation treatment, administering drugs can also play an important role. But how can we know what the right substance is in each individual case? Scientists from the Intelligent…

BIH scientists have been able to observe receptors transmitting signals inside the cell

On June 1, 2019, Professor Christof von Kalle will become a tenured professor of clinical translational sciences at the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin. The cancer expert will head the joint BIH and Charité Clinical Study Center as founding director and BIH…

Stiftung Charité funds new round of BIH Visiting Professors at the Berlin Institute of Health

Proteins are vital parts of all living organisms and perform essential tasks in our bodies. They build and repair tissues, supply components of the immune and hormone systems, regulate metabolism, and transmit signals. Researchers in Berlin and Heidelberg have now developed an intelligent neural…

The Executive Board of the Berlin Institute of Health (BIH) welcomes the administrative agreement reached between the Federal Ministry of Education and Research (BMBF) and the Berlin Senate Chancellery – Higher Education and Research, according to which the BIH is to be integrated into Charité –…

Professor John Ioannidis of Stanford University comes to Berlin as an Einstein BIH Visiting Fellow

Rare diseases are not necessarily that rare: They affect some four million people in Germany alone. But of the estimated 8,000 different diseases that fall into this category, there are often only a few recorded cases of each one. As a result, it can take years for those affected to receive the…